(ABEV) Ambev - Overview
Exchange: NYSE •
Country: Brazil •
Currency: USD •
Type: Common Stock •
ISIN: US02319V1035
Stock:
Total Rating 68
Risk 80
Buy Signal 0.15
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -1.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 49.40 |
| Character TTM | |
|---|---|
| Beta | 0.084 |
| Beta Downside | -0.222 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.91% |
| CAGR/Max DD | 0.30 |
EPS (Earnings per Share)
Revenue
Description: ABEV Ambev
Ambev S.A., through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, soft drinks, malt and food, and other beverages in Brazil, Central America and Caribbean, Latin America South, and Canada. The company offers beer, ready-to-drink cocktails and spritzers, soft drinks, water, teas, and isotonic drinks under the Brahma, Skol, Antarctica, Original, Quilmes, Andes Origen, Patricia, Paceha, Huari, Pilsen, Presidente, Balboa, Guaraná Antarctica, and Beats brands. It sells its products to distributors, supermarkets, and retailers within a broad distribution network. The company was founded in 1853 and is headquartered in São Paulo, Brazil. Ambev S.A. operates as a subsidiary of Interbrew International B.V.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 15.50b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 0.25 > 1.0 |
| NWC/Revenue: -1.95% < 20% (prev 5.33%; Δ -7.28% < -1%) |
| CFO/TA 0.16 > 3% & CFO 24.42b > Net Income 15.50b |
| Net Debt (-13.29b) to EBITDA (28.42b): -0.47 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.66b) vs 12m ago -0.97% < -2% |
| Gross Margin: 50.50% > 18% (prev 0.51%; Δ 4998 % > 0.5%) |
| Asset Turnover: 56.82% > 50% (prev 55.05%; Δ 1.77% > 0%) |
| Interest Coverage Ratio: 9.65 > 6 (EBITDA TTM 28.42b / Interest Expense TTM 2.24b) |
Altman Z'' 2.86
| A: -0.01 (Total Current Assets 43.88b - Total Current Liabilities 45.60b) / Total Assets 148.11b |
| B: 0.12 (Retained Earnings 18.04b / Total Assets 148.11b) |
| C: 0.14 (EBIT TTM 21.59b / Avg Total Assets 155.31b) |
| D: 1.53 (Book Value of Equity 90.86b / Total Liabilities 59.34b) |
| Altman-Z'' Score: 2.86 = A |
Beneish M -3.00
| DSRI: 1.05 (Receivables 10.23b/9.85b, Revenue 88.24b/89.45b) |
| GMI: 1.01 (GM 50.50% / 51.24%) |
| AQI: 1.07 (AQ_t 0.52 / AQ_t-1 0.48) |
| SGI: 0.99 (Revenue 88.24b / 89.45b) |
| TATA: -0.06 (NI 15.50b - CFO 24.42b) / TA 148.11b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = A |
What is the price of ABEV shares?
As of March 04, 2026, the stock is trading at USD 2.94 with a total of 25,921,146 shares traded.
Over the past week, the price has changed by -8.98%, over one month by +1.38%, over three months by +18.55% and over the past year by +53.74%.
Over the past week, the price has changed by -8.98%, over one month by +1.38%, over three months by +18.55% and over the past year by +53.74%.
Is ABEV a buy, sell or hold?
Ambev has received a consensus analysts rating of 3.42.
Therefor, it is recommend to hold ABEV.
- StrongBuy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the ABEV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.1 | 5.4% |
| Analysts Target Price | 3.1 | 5.4% |
ABEV Fundamental Data Overview February 28, 2026
P/E Trailing = 17.7222
P/E Forward = 15.674
P/S = 0.5645
P/B = 2.9211
P/EG = 2.2653
Revenue TTM = 88.24b USD
EBIT TTM = 21.59b USD
EBITDA TTM = 28.42b USD
Long Term Debt = 264.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 5.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -13.29b USD (from netDebt column, last quarter)
Enterprise Value = 34.85b USD (49.82b + Debt 5.35b - CCE 20.32b)
Interest Coverage Ratio = 9.65 (Ebit TTM 21.59b / Interest Expense TTM 2.24b)
EV/FCF = 1.76x (Enterprise Value 34.85b / FCF TTM 19.83b)
FCF Yield = 56.92% (FCF TTM 19.83b / Enterprise Value 34.85b)
FCF Margin = 22.48% (FCF TTM 19.83b / Revenue TTM 88.24b)
Net Margin = 17.57% (Net Income TTM 15.50b / Revenue TTM 88.24b)
Gross Margin = 50.50% ((Revenue TTM 88.24b - Cost of Revenue TTM 43.68b) / Revenue TTM)
Gross Margin QoQ = 49.32% (prev 51.46%)
Tobins Q-Ratio = 0.24 (Enterprise Value 34.85b / Total Assets 148.11b)
Interest Expense / Debt = 16.15% (Interest Expense 864.1m / Debt 5.35b)
Taxrate = 23.64% (1.40b / 5.93b)
NOPAT = 16.49b (EBIT 21.59b * (1 - 23.64%))
Current Ratio = 0.96 (Total Current Assets 43.88b / Total Current Liabilities 45.60b)
Debt / Equity = 0.06 (Debt 5.35b / totalStockholderEquity, last quarter 87.91b)
Debt / EBITDA = -0.47 (Net Debt -13.29b / EBITDA 28.42b)
Debt / FCF = -0.67 (Net Debt -13.29b / FCF TTM 19.83b)
Total Stockholder Equity = 91.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.98% (Net Income 15.50b / Total Assets 148.11b)
RoE = 16.90% (Net Income TTM 15.50b / Total Stockholder Equity 91.74b)
RoCE = 23.47% (EBIT 21.59b / Capital Employed (Equity 91.74b + L.T.Debt 264.1m))
RoIC = 17.30% (NOPAT 16.49b / Invested Capital 95.28b)
WACC = 6.76% (E(49.82b)/V(55.17b) * Re(6.16%) + D(5.35b)/V(55.17b) * Rd(16.15%) * (1-Tc(0.24)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.54%
[DCF] Terminal Value 83.96% ; FCFF base≈20.44b ; Y1≈22.53b ; Y5≈28.98b
[DCF] Fair Price = 43.35 (EV 663.67b - Net Debt -13.29b = Equity 676.96b / Shares 15.62b; r=6.76% [WACC]; 5y FCF grow 11.74% → 2.90% )
EPS Correlation: 53.02 | EPS CAGR: 68.02% | SUE: 4.0 | # QB: 1
Revenue Correlation: 57.96 | Revenue CAGR: 8.23% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.04 | Chg7d=+0.001 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.19 | Chg7d=+0.002 | Chg30d=+0.001 | Revisions Net=-1 | Growth EPS=+7.0% | Growth Revenue=+4.8%
EPS next Year (2027-12-31): EPS=0.21 | Chg7d=+0.005 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+11.1% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 7.9% - Earnings Yield 5.6%)
[Growth] Growth Spread = +2.4% (Analyst 4.7% - Implied 2.3%)
P/E Forward = 15.674
P/S = 0.5645
P/B = 2.9211
P/EG = 2.2653
Revenue TTM = 88.24b USD
EBIT TTM = 21.59b USD
EBITDA TTM = 28.42b USD
Long Term Debt = 264.1m USD (from longTermDebt, two quarters ago)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 5.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -13.29b USD (from netDebt column, last quarter)
Enterprise Value = 34.85b USD (49.82b + Debt 5.35b - CCE 20.32b)
Interest Coverage Ratio = 9.65 (Ebit TTM 21.59b / Interest Expense TTM 2.24b)
EV/FCF = 1.76x (Enterprise Value 34.85b / FCF TTM 19.83b)
FCF Yield = 56.92% (FCF TTM 19.83b / Enterprise Value 34.85b)
FCF Margin = 22.48% (FCF TTM 19.83b / Revenue TTM 88.24b)
Net Margin = 17.57% (Net Income TTM 15.50b / Revenue TTM 88.24b)
Gross Margin = 50.50% ((Revenue TTM 88.24b - Cost of Revenue TTM 43.68b) / Revenue TTM)
Gross Margin QoQ = 49.32% (prev 51.46%)
Tobins Q-Ratio = 0.24 (Enterprise Value 34.85b / Total Assets 148.11b)
Interest Expense / Debt = 16.15% (Interest Expense 864.1m / Debt 5.35b)
Taxrate = 23.64% (1.40b / 5.93b)
NOPAT = 16.49b (EBIT 21.59b * (1 - 23.64%))
Current Ratio = 0.96 (Total Current Assets 43.88b / Total Current Liabilities 45.60b)
Debt / Equity = 0.06 (Debt 5.35b / totalStockholderEquity, last quarter 87.91b)
Debt / EBITDA = -0.47 (Net Debt -13.29b / EBITDA 28.42b)
Debt / FCF = -0.67 (Net Debt -13.29b / FCF TTM 19.83b)
Total Stockholder Equity = 91.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.98% (Net Income 15.50b / Total Assets 148.11b)
RoE = 16.90% (Net Income TTM 15.50b / Total Stockholder Equity 91.74b)
RoCE = 23.47% (EBIT 21.59b / Capital Employed (Equity 91.74b + L.T.Debt 264.1m))
RoIC = 17.30% (NOPAT 16.49b / Invested Capital 95.28b)
WACC = 6.76% (E(49.82b)/V(55.17b) * Re(6.16%) + D(5.35b)/V(55.17b) * Rd(16.15%) * (1-Tc(0.24)))
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.54%
[DCF] Terminal Value 83.96% ; FCFF base≈20.44b ; Y1≈22.53b ; Y5≈28.98b
[DCF] Fair Price = 43.35 (EV 663.67b - Net Debt -13.29b = Equity 676.96b / Shares 15.62b; r=6.76% [WACC]; 5y FCF grow 11.74% → 2.90% )
EPS Correlation: 53.02 | EPS CAGR: 68.02% | SUE: 4.0 | # QB: 1
Revenue Correlation: 57.96 | Revenue CAGR: 8.23% | SUE: -0.02 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.04 | Chg7d=+0.001 | Chg30d=-0.000 | Revisions Net=-1 | Analysts=1
EPS current Year (2026-12-31): EPS=0.19 | Chg7d=+0.002 | Chg30d=+0.001 | Revisions Net=-1 | Growth EPS=+7.0% | Growth Revenue=+4.8%
EPS next Year (2027-12-31): EPS=0.21 | Chg7d=+0.005 | Chg30d=-0.006 | Revisions Net=+0 | Growth EPS=+11.1% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.3% (Discount Rate 7.9% - Earnings Yield 5.6%)
[Growth] Growth Spread = +2.4% (Analyst 4.7% - Implied 2.3%)